Clinical Trial Update: Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Cerebrolysin for infants with a history of neonatal hypoxic-ischemic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Sahar M.A. Hassanein, MD | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 2 | Status: COMPLETED